
Stock Market: At 7:30 am, the Nifty futures had gained 0.5 per cent on Singapore Stock Exchange.
The markets are set to start the week on a positive note, after closing at around record highs in the previous week, as hopes of a coronavirus vaccine continue to buoy investor sentiment globally. The Asian markets have edged higher in early trading and trends on SGX Nifty indicate a positive opening for the index in India, with a 50-points gain. At 7:30 am, the Nifty futures were trading at 12,932, higher by 50 points or 0.5 per cent on the Singapore Stock Exchange.
Asian Markets
A broad gauge of Asian shares edged up to record highs on Monday morning amid coronavirus vaccines hopes, but worries over the impact of economic lockdowns and uncertainty over U.S. stimulus capped gains. MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.38 per cent.
Trading activity was thin early in the Asian day, with Japanese markets closed for a holiday. Nikkei futures added 0.16 per cent to 25,785 and Seoul's Kospi was 0.84 per cent higher.
What Happened In Previous Trading Session
The BSE Sensex climbed 282.29 points to 43,882.25 and NSE Nifty had rose 87.30 points to 12,859 in Friday's session. The benchmark indices resumed their upmove after a day's pause, led by gains in information technology, banking and telecom shares. All the 19 sector gauges, barring the index of energy shares, ended higher led by the S&P BSE Telecom index's nearly 5 per cent gain. FMCG, consumer durables, power, banking, auto and IT indexes also rose 1-2.8 per cent each.
Equity markets elsewhere in Asia moved higher with cautious gains. MSCI's broadest index of Asia-Pacific shares outside Japan was last seen trading 0.38 per cent higher.
Trading activity was thin in early deals, with Japanese markets closed for a holiday. Japan's Nikkei futures added 0.16 per cent, and South Korea's Kospi was up 0.84 per cent.
Domestic share markets are set to start the week on a positive note, after closing near record highs in the previous session, as hopes of a coronavirus vaccine continue to buoy investor sentiment globally.